InfuSystem Holdings Business Summary

InfuSystem Holdings, Inc. (INFU) operates as a leading national provider of ambulatory infusion pumps and specialized healthcare services, primarily generating revenue through its Patient Services and Device Solutions segments. The Patient Services division utilizes a recurring revenue model by supplying electronic ambulatory infusion pumps and disposable kits to oncology clinics and outpatient facilities, billing third-party insurers for the treatment of cancers, chronic pain, and advanced wounds. Conversely, the Device Solutions segment generates transaction-based revenue through the sale and rental of new and pre-owned medical equipment, alongside high-margin biomedical services including maintenance, repair, and recertification. Positioned as a specialized niche leader in the ambulatory infusion market, InfuSystem competes directly with diversified medical technology giants such as Baxter International, Medtronic, B. Braun, and Omnicell, distinguishing itself through a comprehensive "last-mile" service model that integrates clinical support with equipment management. Originally emerging as a 2005 spin-off from I-Flow Corporation before its 2007 acquisition by HAPC, Inc., the company is currently led by President and CEO Carrie Lachance, a registered nurse with over 20 years of clinical experience who previously served as the firm's COO. The executive suite is further bolstered by EVP and CFO Barry Steele, who brings over two decades of financial leadership from roles at Gentherm and Horizon Global, and EVP and CIO Addam Chupa, who oversees the company’s enterprise technology and digital transformation initiatives. Strategic oversight is provided by a board chaired by Ronald Hundzinski, a former CFO of TI Fluid Systems, and includes notable directors such as Scott Shuda and Dr. John J. Sviokla. The company maintains a strong institutional investor base, with significant positions held by firms including The Vanguard Group, Punch & Associates, and Minerva Advisors.